Health groups urge Bhattacharya, in his position of acting CDC director, to restore staff in the Office on Smoking and Health

Calabresi’s “Cancer at a Crossroads” report was the first step toward historic doubling of the NIH budget
Fox Chase’s Winn contemplates Crossroads 2.0

At a lecture at Yale Cancer Center recently, Robert A. Winn brandished a copy of a 32-year old booklet titled “Cancer at a Crossroads: A Report to Congress for the Nation,” using it as a show-and-tell prop in arguing that America’s cancer program is once again at a crossroads and therefore in urgent need of strategic thinking (The Cancer Letter, April 10, 2026).

E-cigarette taxes reduce vaping; no increase in adult smoking, OSU study finds

For years, a central debate in tobacco policy has been whether taxing e-cigarettes might unintentionally drive vapers back to traditional cigarettes.

April 17, 2026

Vol.52 No.15

Conversation with The Cancer Letter

Letai: Perceptions aside, money is flowing and the cancer research infrastructure is sturdy
NCI expects record-breaking spending on extramural research

Over the course of his first six months as NCI director, Anthony Letai has contended with federal budget turbulence, a record-setting government shutdown, and concerns about the flow of over research dollars.

April 10, 2026

Vol.52 No.14

By Claire Marie Porter and Paul Goldberg

Cancer Policy

President’s budget request would cap indirect costs and fully fund all NIH research projects upfront

NCI has emerged relatively unscathed in the president’s FY 2027 budget request that would slash $15.8 billion from HHS funding, cut NIH overall by about 10%, eliminate three NIH institutes and centers, and move the Institute for Environmental Health Sciences and its circa $1 billion budget out of NIH.

April 10, 2026

Vol.52 No.14

By Claire Marie Porter and Jacquelyn Cobb

NCI

Hoping to hit a $200M target, NCI and FNIH develop a plan for advancing cancer vaccines
NCI Director Letai: “How aggressive can we be?”

A public-private effort, spearheaded by NCI Director Anthony Letai, and led by the Foundation for the National Institutes of Health, is working to speed up the development of therapeutic cancer vaccines.

March 20, 2026

Vol.52 No.11

By Claire Marie Porter

Cancer Policy

The reconstitution of ACIP and changes to CDC’s childhood vaccine schedule were likely illegal, judge rules

Judge Brian E. Murphy, of the U.S. District Court for the District of Massachusetts, temporarily blocked a series of recent changes to the CDC vaccine schedule.

March 20, 2026

Vol.52 No.11

By Sara Willa Ernst

Health groups urge Bhattacharya, in his position of acting CDC director, to restore staff in the Office on Smoking and Health

YOU MAY BE INTERESTED IN

Calabresi’s “Cancer at a Crossroads” report was the first step toward historic doubling of the NIH budget
Fox Chase’s Winn contemplates Crossroads 2.0

E-cigarette taxes reduce vaping; no increase in adult smoking, OSU study finds

Letai: Perceptions aside, money is flowing and the cancer research infrastructure is sturdy
NCI expects record-breaking spending on extramural research

President’s budget request would cap indirect costs and fully fund all NIH research projects upfront

Hoping to hit a $200M target, NCI and FNIH develop a plan for advancing cancer vaccines
NCI Director Letai: “How aggressive can we be?”

The reconstitution of ACIP and changes to CDC’s childhood vaccine schedule were likely illegal, judge rules

Renew today!

Subscriber content

Never miss an issue!

Login

Health groups urge Bhattacharya, in his position of acting CDC director, to restore staff in the Office on Smoking and Health

YOU MAY BE INTERESTED IN

Calabresi’s “Cancer at a Crossroads” report was the first step toward historic doubling of the NIH budgetFox Chase’s Winn contemplates Crossroads 2.0

E-cigarette taxes reduce vaping; no increase in adult smoking, OSU study finds

Letai: Perceptions aside, money is flowing and the cancer research infrastructure is sturdyNCI expects record-breaking spending on extramural research

President’s budget request would cap indirect costs and fully fund all NIH research projects upfront

Hoping to hit a $200M target, NCI and FNIH develop a plan for advancing cancer vaccinesNCI Director Letai: “How aggressive can we be?”

The reconstitution of ACIP and changes to CDC’s childhood vaccine schedule were likely illegal, judge rules

Never miss an issue!

Login

Calabresi’s “Cancer at a Crossroads” report was the first step toward historic doubling of the NIH budget
Fox Chase’s Winn contemplates Crossroads 2.0

Letai: Perceptions aside, money is flowing and the cancer research infrastructure is sturdy
NCI expects record-breaking spending on extramural research

Hoping to hit a $200M target, NCI and FNIH develop a plan for advancing cancer vaccines
NCI Director Letai: “How aggressive can we be?”